MedTrace Logo

Guided ADHD Therapy for Managing the Extent and Severity of Symptoms

NCT05296473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 560

Last updated 2024-09-19

No results posted yet for this study

Summary

The objective of this study is to assess the safety and effectiveness of an at-home, game-based digital therapy for treating adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD).

Conditions

  • ADHD

Interventions

DEVICE

ADHD Therapy

investigational game-play therapy

DEVICE

Control Therapy

control game-play therapy

Sponsors & Collaborators

  • Lumos Labs, Inc.

    lead INDUSTRY

Principal Investigators

  • Ann Childress, MD · Clinical Research of Southern Nevada, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-05
Primary Completion
2024-03-12
Completion
2024-03-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05296473 on ClinicalTrials.gov